Global Candidiasis Therapeutics Market Status and Outlook 2018-2025

August 2018 | 143 pages | ID: G4FEDA1F3C7EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Novartis AG
• Amgen
• F. Hoffmann-La Roche Ltd.
• Bayer-Algeta
• Merrion Pharmaceuticals Plc.
• Ablynx
• Genta Incorporated
• Galapagos NV
• Catena Pharmaceuticals Inc.
• Digna Biotech S.L.
• Medivir AB
• Amura Holdings

Market by Type

• Doxorubicin
• Cisplatin
• 7Carboplatin
• Etoposide
• Ifosfamide
• Cyclophosphamide
• Methotrexate
• Vincristine

Market by Application

• Multispecialty Hospitals
• Cancer Research Institutes
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Candidiasis Therapeutics Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Doxorubicin
  3.1.2 Cisplatin
  3.1.3 7Carboplatin
  3.1.4 Etoposide
  3.1.5 Ifosfamide
  3.1.6 Cyclophosphamide
  3.1.7 Methotrexate
  3.1.8 Vincristine
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Multispecialty Hospitals
  4.1.2 Cancer Research Institutes
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Doxorubicin Production by Region
    6.1.1.2 Cisplatin Production by Region
    6.1.1.3 7Carboplatin Production by Region
    6.1.1.4 Etoposide Production by Region
    6.1.1.5 Ifosfamide Production by Region
    6.1.1.6 Cyclophosphamide Production by Region
    6.1.1.7 Methotrexate Production by Region
    6.1.1.8 Vincristine Production by Region
  6.1.2 Production by Application
    6.1.2.1 Multispecialty Hospitals Production by Region
    6.1.2.2 Cancer Research Institutes Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Doxorubicin Demand by Region
    6.2.1.2 Cisplatin Demand by Region
    6.2.1.3 7Carboplatin Demand by Region
    6.2.1.4 Etoposide Demand by Region
    6.2.1.5 Ifosfamide Demand by Region
    6.2.1.6 Cyclophosphamide Demand by Region
    6.2.1.7 Methotrexate Demand by Region
    6.2.1.8 Vincristine Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Multispecialty Hospitals Demand by Region
    6.2.2.2 Cancer Research Institutes Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novartis AG
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Amgen
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 F. Hoffmann-La Roche Ltd.
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Bayer-Algeta
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Merrion Pharmaceuticals Plc.
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Ablynx
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Genta Incorporated
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Galapagos NV
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Catena Pharmaceuticals Inc.
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Digna Biotech S.L.
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Medivir AB
8.12 Amura Holdings

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Candidiasis Therapeutics Industry Dynamics & Regulations List
Table Global Candidiasis Therapeutics Sales Revenue, Cost and Margin, 2015-2018E
Table Global Candidiasis Therapeutics Market Status by Type 2015-2018E, in USD Million
Table Global Candidiasis Therapeutics Market Status by Application 2015-2018E, in USD Million
Table Global Candidiasis Therapeutics Market Status by Application 2015-2018E, in Volume
Table Global Candidiasis Therapeutics Market by Region 2015-2018E, in USD Million
Table Global Candidiasis Therapeutics Market Share by Region in 2018, in USD Million
Table Global Candidiasis Therapeutics Market by Region 2015-2018E, in Volume
Table Global Candidiasis Therapeutics Market Share by Region in 2018, in Volume
Table Doxorubicin Production Value by Region 2015-2018E, in USD Million
Table Doxorubicin Production Volume by Region 2015-2018E, in Volume
Table Cisplatin Production Value by Region 2015-2018E, in USD Million
Table Cisplatin Production Volume by Region 2015-2018E, in Volume
Table 7Carboplatin Production Value by Region 2015-2018E, in USD Million
Table 7Carboplatin Production Volume by Region 2015-2018E, in Volume
Table Etoposide Production Value by Region 2015-2018E, in USD Million
Table Etoposide Production Volume by Region 2015-2018E, in Volume
Table Ifosfamide Production Value by Region 2015-2018E, in USD Million
Table Ifosfamide Production Volume by Region 2015-2018E, in Volume
Table Cyclophosphamide Production Value by Region 2015-2018E, in USD Million
Table Cyclophosphamide Production Volume by Region 2015-2018E, in Volume
Table Methotrexate Production Value by Region 2015-2018E, in USD Million
Table Methotrexate Production Volume by Region 2015-2018E, in Volume
Table Vincristine Production Value by Region 2015-2018E, in USD Million
Table Vincristine Production Volume by Region 2015-2018E, in Volume
Table Multispecialty Hospitals Production Value by Region 2015-2018E, in USD Million
Table Multispecialty Hospitals Production Volume by Region 2015-2018E, in Volume
Table Cancer Research Institutes Production Value by Region 2015-2018E, in USD Million
Table Cancer Research Institutes Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Doxorubicin Market Size by Region 2015-2018E, in USD Million
Table Doxorubicin Market Size by Region 2015-2018E, in Volume
Table Cisplatin Market Size by Region 2015-2018E, in USD Million
Table Cisplatin Market Size by Region 2015-2018E, in Volume
Table 7Carboplatin Market Size by Region 2015-2018E, in USD Million
Table 7Carboplatin Market Size by Region 2015-2018E, in Volume
Table Etoposide Market Size by Region 2015-2018E, in USD Million
Table Etoposide Market Size by Region 2015-2018E, in Volume
Table Ifosfamide Market Size by Region 2015-2018E, in USD Million
Table Ifosfamide Market Size by Region 2015-2018E, in Volume
Table Cyclophosphamide Market Size by Region 2015-2018E, in USD Million
Table Cyclophosphamide Market Size by Region 2015-2018E, in Volume
Table Methotrexate Market Size by Region 2015-2018E, in USD Million
Table Methotrexate Market Size by Region 2015-2018E, in Volume
Table Vincristine Market Size by Region 2015-2018E, in USD Million
Table Vincristine Market Size by Region 2015-2018E, in Volume
Table Multispecialty Hospitals Market Size by Region 2015-2018E, in USD Million
Table Multispecialty Hospitals Market Size by Region 2015-2018E, in Volume
Table Cancer Research Institutes Market Size by Region 2015-2018E, in USD Million
Table Cancer Research Institutes Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCandidiasis Therapeutics Forecast by Type 2019F-2025F, in USD Million
Table Candidiasis Therapeutics Forecast by Type 2019F-2025F, in Volume
Table Candidiasis Therapeutics Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Candidiasis Therapeutics Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Candidiasis Therapeutics Market Forecast by Region 2019F-2025F, in USD Million
Table Candidiasis Therapeutics Market Forecast by Region 2019F-2025F, in Volume
Table Novartis AG Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Novartis AG
Table Amgen Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Amgen
Table F. Hoffmann-La Roche Ltd. Information
Table Candidiasis Therapeutics Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Bayer-Algeta Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Bayer-Algeta
Table Merrion Pharmaceuticals Plc. Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Merrion Pharmaceuticals Plc.
Table Ablynx Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Ablynx
Table Genta Incorporated Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Genta Incorporated
Table Galapagos NV Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Galapagos NV
Table Catena Pharmaceuticals Inc. Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Catena Pharmaceuticals Inc.
Table Digna Biotech S.L. Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Digna Biotech S.L.
Table Medivir AB Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Medivir AB
Table Amura Holdings Information
Table Candidiasis Therapeutics Sales, Cost, Margin of Amura Holdings
Table Global Candidiasis Therapeutics Sales Revenue by Company 2015-2017, in USD Million
Table Global Candidiasis Therapeutics Sales Volume by Company 2015-2017, in Volume
Table Global Candidiasis Therapeutics Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Candidiasis Therapeutics Picture
Figure Candidiasis Therapeutics Industry Chain Diagram
Figure Global Candidiasis Therapeutics Sales Revenue 2015-2018E, in USD Million
Figure Global Candidiasis Therapeutics Sales Volume 2015-2018E, in Volume
Figure Global Candidiasis Therapeutics Market Status by Type 2015-2018E, in Volume
Figure North America Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure North America Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Europe Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Europe Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure South America Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure South America Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Middle East Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Africa Candidiasis Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Africa Candidiasis Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Global Candidiasis Therapeutics Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Candidiasis Therapeutics Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Candidiasis Therapeutics Sales Price Forecast 2019F-2025F
Figure Global Candidiasis Therapeutics Gross Margin Forecast 2019F-2025F
Figure Global Candidiasis Therapeutics Sales Revenue by Company in 2018, in USD Million
Figure Global Candidiasis Therapeutics Price by Company in 2018
Figure Global Candidiasis Therapeutics Gross Margin by Company in 2018